General
Preferred name
AMILORIDE
Synonyms
AMILORIDE HYDROCHLORIDE ()
Midamor ()
Amiloride hydrochloride dihydrate ()
Amiloride HCl 2H2O ()
Amiloride HCl 2H2O ()
Amiloride HCl ()
Amiloride (hydrochloride) ()
Amiloride hydrochloride hydrate ()
Amiloride (MK-870) HCl ()
Amiloride HCl dihydrate ()
MK-870 HCl ()
MK-870 hydrochloride dihydrate ()
MK-870 ()
MK-870 hydrochloride ()
Amipramidine ()
Amiloridi hydrochloridum ()
Amiloride hydrochloride component of moduretic ()
Berkamil ()
NSC-755847 ()
Amiloride hydrochloride anhydrous ()
Amilamont ()
Amiloride hydrochloride dehydrate ()
Anhydrous amiloride hydrochloride ()
Amiloride hydrochloride component of hydro-ride ()
Amoride ()
Amilospare 5 ()
Hydro-Ride ()
Amilorida ()
Amiclaran ()
Amiloride (hydrochloride) (hydrate) ()
P&D ID
PD009902
CAS
17440-83-4
2609-46-3
2016-88-8
Tags
available
drug
Approved by
FDA
First approval
1981
Drug indication
Hypertension
Cardiovascular disease
Congestive heart failure
Drug Status
approved
investigational
Max Phase
4.0
Probe control
Probe control not defined
Orthogonal probes
0
No orthogonal probes found
Similar probes
0
No structurally similar probes found
Structure formats
[[ format ]]
[[ compound[format === 'MOL' ? 'molblock' : format.toLowerCase()] ]]
Description
(extracted from source data)
PRICE
29
DESCRIPTION
Amiloride hydrochloride (MK-870 hydrochloride) is an inhibitor of both epithelial sodium channel (ENaC[1]) and urokinase-type plasminogen activator receptor (uTPA[2]). Amiloride hydrochloride is a blocker of polycystin-2 (PC2; TRPP2[3]) channel.
DESCRIPTION
Amiloride hydrochloride (Amiloride HCl) is an effective sodium channel blocker of epithelial.
DESCRIPTION
Amiloride hydrochloride dihydrate (MK-870 hydrochloride dihydrate) is an inhibitor of both epithelial sodium channel (ENaC[1]) and urokinase-type plasminogen activator receptor (uTPA[2]). Amiloride hydrochloride dihydrate is a blocker of polycystin-2 (PC2; TRPP2[3]) channel.
DESCRIPTION
Amiloride is a loop diuretic drug.
(GtoPdb)
DESCRIPTION
Amiloride (MK-870) is an inhibitor of both epithelial sodium channel (ENaC[1]) and urokinase-type plasminogen activator receptor (uTPA[2]). Amiloride is a blocker of polycystin-2 (PC2; TRPP2[3]) channel.
DESCRIPTION
NMDA antagonist; acts at glycine site
(Tocris Bioactive Compound Library)
DESCRIPTION
Epithelial Na+ channel blocker
(LOPAC library)
DESCRIPTION
Amiloride HCl is a relatively selective inhibitor of the epithelial sodium channel, used in the management of hypertension and congestive heart failure.
(BOC Sciences Bioactive Compounds)
DESCRIPTION
Na+ channel blocker. Also I2 imidazoline ligand
(Tocriscreen Total)
DESCRIPTION
Amiloride is a pyrazine compound inhibiting sodium reabsorption through sodium channels in renal epithelial cells. This inhibition creates a negative potential in the luminal membranes of principal cells, located in the distal convoluted tubule and collecting duct. Negative potential reduces secretion of potassium and hydrogen ions. Amiloride is used in conjunction with diuretics to spare potassium loss. It is indicated for use as adjunctive treatment with thiazide diuretics or other kaliuretic-diuretic agents in congestive heart failure or hypertension.
(Enamine Bioactive Compounds)
[[ p.pathway_name ]]
[[ compound.targets[tid].gene_name ]]
Cell lines
1
Organisms
2
Compound Sets
38
BOC Sciences Bioactive Compounds
CeMM library of unique drugs (CLOUD)
ChEMBL Approved Drugs
ChEMBL Drugs
Concise Guide to Pharmacology 2017/18
Concise Guide to Pharmacology 2019/20
Concise Guide to Pharmacology 2021/22
Concise Guide to Pharmacology 2023/24
Concise Guide to Pharmacology 2025/26
CZ-OPENSCREEN Bioactive Library
Drug Repurposing Hub
DrugBank
DrugBank Approved Drugs
DrugCentral
DrugCentral Approved Drugs
DrugMAP
DrugMAP Approved Drugs
DrugMatrix
Enamine Bioactive Compounds
Enamine BioReference Compounds
EU-OPENSCREEN Bioactive Compound Library
Guide to Pharmacology
JUMP-Target 1 Compound Set
Ki Database
LOPAC library
LSP-MoA library (Laboratory of Systems Pharmacology)
NCATS Inxight Approved Drugs
NIH Clinical Collections (NCC)
NPC Screening Collection
Prestwick Chemical Library
ReFrame library
Selleckchem Bioactive Compound Library
The Spectrum Collection
Tocris Bioactive Compound Library
Tocriscreen Total
[[ a.name ]]
[[ ligand_id ]]
free of charge
External IDs
222
Molecular Weight
229.05
Hydrogen Bond Acceptors
6
Hydrogen Bond Donors
5
Rotatable Bonds
1
Ring Count
1
Aromatic Ring Count
1
cLogP
-1.08
TPSA
156.79
Fraction CSP3
0.0
Chiral centers
0.0
Largest ring
6.0
QED
0.3
Structural alerts
0
No structural alerts detected
Custom attributes
(extracted from source data)
Selectivity
Epithelial
MOA
amiloride-sensitive sodium channel inhibitor
Serine Protease inhibitor
Blocker
Sodium Channel blocker
Target
Amiloride-sensitive sodium channel, ENaC
AOC1, ASIC1, ASIC2, ASIC3, PKD2, PKD2L1, PLAU, SCNN1A, SCNN1B, SCNN1D, SCNN1G, SLC9A1, TRPC7, TRPV2
ASIC1
Calcium Channel,Serine Protease,Sodium Channel
Sodium Channel
TRP Channel
Primary Target
Voltage-gated Sodium (NaV) Channels
Indication
hypertension, congestive heart failure
Therapeutic Class
Diuretics
Pathway
Apoptosis
Membrane Transporter/Ion Channel
Neuronal Signaling
Solubility
Well in water and ethanol
Source data

